XML 56 R39.htm IDEA: XBRL DOCUMENT v3.24.3
Note 8 - Goodwill and Intangible Assets (Tables)
12 Months Ended
Sep. 30, 2024
Notes Tables  
Schedule of Goodwill [Table Text Block]
   Life Sciences Products   Life Sciences Services   Sample Management Solutions   Multiomics   B Medical Systems   Total 

Balance - September 30, 2022

 $154,612  $359,011  $  $  $  $513,623 

Acquisitions

  242,789               242,789 

Currency translation adjustments

  27,903   24            27,927 

Balance - September 30, 2023

 $425,304  $359,035  $  $  $  $784,339 

Segment recast (1)

  (425,304)  (359,035)  478,601   196,760   108,978    

Impairment

              (111,317)  (111,317)

Currency translation adjustments

        16,048      2,339   18,387 

Balance - September 30, 2024

 $  $  $494,649  $196,760  $  $691,409 
                         

Accumulated goodwill impairments, September 30, 2024

 $-  $-  $-  $-  $(111,317) $(111,317)
Schedule of Finite-Lived Intangible Assets [Table Text Block]
  

September 30, 2024

  

September 30, 2023

 
      

Accumulated

  

Net Book

      

Accumulated

  

Net Book

 
  

Cost

  

Amortization

  

Value

  

Cost

  

Amortization

  

Value

 

Patents

 $1,227  $1,227  $  $1,226  $1,175  $51 

Completed technology

  224,487   82,736   141,751   215,430   56,021   159,409 

Trademarks and trade names

  6,988   3,133   3,855   6,630   1,445   5,185 

Non-competition agreements

           681   568   113 

Customer relationships

  289,821   187,397   102,424   290,800   161,257   129,543 

Other intangibles

  683   683      869   869    

Total

 $523,206  $275,176  $248,030  $515,636  $221,335  $294,301 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

2025

 $50,051 

2026

  45,502 

2027

  37,285 

2028

  30,793 

2029

  25,007 

Thereafter

  59,392 

Total

 $248,030